Fecal transplants from exercised diabetic mice increased GLP-1 levels by 0.92 pmol/L and enhanced blood vessel repair cell function in recipient mice, linking exercise benefits to gut microbiota changes.
+0.92 pmol/L GLP-1Fecal microbiota transplant from exercised mice increased GLP-1 more than exercise itself in diabetic recipients
What the researchers found
Eight weeks of exercise (aerobic, resistance, or combined) in diabetic mice altered gut microbiota composition, increasing Prevotellaceae and Ligilactobacillus. Fecal microbiota transplantation (FMT) from exercised donors to recipient mice:
- Elevated plasma GLP-1 by 0.92 pmol/L (P < 0.001) — surpassing exercise's own modest, non-significant GLP-1 increase
- Enriched Akkermansia in recipient gut
- Enhanced endothelial progenitor cell proliferation (P < 0.007) and migration (P < 0.05)
- Reduced blood glucose by 9.22 mmol/L (P < 0.001)
- Exercise alone reduced body weight by 10.58 g (P < 0.001, aerobic training)
Why it matters
This study reveals a fascinating mechanism: exercise increases GLP-1 (the same peptide targeted by semaglutide and other drugs) through changing gut bacteria. This means the gut microbiome may be a natural 'pharmacy' for GLP-1 production, and therapies targeting specific gut bacteria could potentially boost endogenous GLP-1 without drugs.
How the study worked
Type 2 diabetic mice underwent 8 weeks of aerobic, resistance, or combined exercise. Mice with the best outcomes donated fecal material for gut microbiota transplantation to sedentary diabetic recipients. Both groups were assessed for glucose, weight, GLP-1 levels, gut bacterial composition (16S sequencing), and endothelial progenitor cell function (proliferation and migration assays).
What this study cannot tell us
Mouse study results may not translate to humans. FMT from 'best performing' exercise mice introduces selection bias. The GLP-1 increase from FMT, while statistically significant, was modest in absolute terms. The mechanism by which specific gut bacteria increase GLP-1 secretion wasn't elucidated. Long-term effects and the durability of FMT benefits were not assessed.
How to read the evidence
Preclinical mouse study with a creative experimental design (exercise → FMT → outcome assessment). While the approach is innovative, all findings are in mice and the mechanisms require further elucidation.
When this study was published
Published in 2025 in Frontiers in Cellular and Infection Microbiology, this is a recent study at the intersection of exercise science, microbiome research, and peptide biology.
The bigger picture
The gut microbiome is increasingly recognized as a major regulator of metabolic peptide hormones including GLP-1. This study adds evidence that exercise's well-known metabolic benefits are partly mediated through gut bacteria that stimulate endogenous GLP-1 secretion. This gut-peptide-cardiovascular axis could be targeted therapeutically through probiotics, prebiotics, or dietary interventions.
Questions still open
- Could specific probiotic supplements containing Prevotellaceae, Ligilactobacillus, or Akkermansia boost natural GLP-1 production in humans?
- Does this gut microbiota-GLP-1 pathway explain why exercise is particularly effective for diabetes management?
- Would combining exercise with GLP-1 RA drugs produce synergistic benefits through both endogenous and exogenous GLP-1 elevation?
Common questions
Can exercise increase your body's natural GLP-1 levels?
What is Akkermansia and why does it matter?
Read the original research
Exercise improves endothelial progenitor cell's function in mice with Type 2 diabetes via gut microbiota modulation.
Frontiers in cellular and infection microbiology, 15, 1606652
Citation
Dai, Xia; Chen, Haiyan; Zhang, Milei; Yang, Qiong; Huang, Zheng; Tang, LiAn. (2025). Exercise improves endothelial progenitor cell's function in mice with Type 2 diabetes via gut microbiota modulation.. Frontiers in cellular and infection microbiology, 15, 1606652. https://doi.org/10.3389/fcimb.2025.1606652